Nicotinell Tts Nch (Nicotine)

Nicotinell Tts Nch is a nicotine replacement therapy used in smoking cessation.

• Smoking cessation: Provides a controlled release of nicotine to alleviate withdrawal symptoms and reduce cravings.
• Tobacco dependence: Supports a gradual reduction in nicotine intake as part of a quit plan.
• Relapse prevention: Helps maintain abstinence after quitting by stabilising nicotine levels.

• Nicotine in the patch acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By binding to these receptors, it mimics the pharmacological effects of tobacco‑derived nicotine, producing mild stimulation that eases withdrawal while avoiding the harmful combustion products of smoking. The transdermal delivery system ensures steady plasma concentrations over several hours, reducing the peaks and troughs that drive cravings.

The following adverse reactions have been reported with nicotine transdermal patches.

Common Side Effects

• Skin irritation at the application site: redness, itching, or mild rash.
• Sleep disturbance: difficulty falling asleep or vivid dreams.
• Headache: mild to moderate tension‑type headache.

Serious or Rare Side Effects

• Allergic reaction: swelling, hives, or severe rash requiring medical attention.
• Chest pain or palpitations: may indicate cardiovascular stress.
• Dizziness or fainting: especially when standing up quickly.

Before using Nicotinell Tts Nch, consider the following safety measures.

• Cardiovascular assessment: evaluate heart disease risk before initiating therapy.
• Comprehensive quit plan: combine the patch with counseling or behavioral support.
• Avoid use in non‑smokers: nicotine exposure is unnecessary and may cause adverse effects.
• Do not apply to damaged or irritated skin: use only on clean, intact areas.
• Keep away from heat sources: avoid external heat that could increase nicotine release.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine patches can interact with other substances that affect nicotine levels or cardiovascular response.

Major Interactions (Avoid)

• Concomitant use of other nicotine products (gum, inhaler, lozenge): may lead to excessive nicotine exposure.
• Use with monoamine oxidase inhibitors (MAOIs): can increase the risk of hypertensive reactions.

Moderate Interactions (Monitor Closely)

• CYP2A6 inhibitors (e.g., methoxsalen): may slow nicotine metabolism, raising plasma levels.
• Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring careful monitoring.
• Certain antidepressants (e.g., bupropion): may increase seizure risk when combined with nicotine.